Fortschritte der Neurologie · Psychiatrie, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 23, 2024
Introduction Preclinically, fluvoxamine and other antidepressants (AD) exerted antiviral anti-inflammatory properties also against SARS-COV-2. Therfore, It makes sense to test the clinical effect of AD COVID-19 Long COVID.
Language: Английский